To access this element change to forms mode OFF

Archived Grant Opportunity View - GO4813

2021 Priority-driven Collaborative Cancer Research Scheme for funding commencing in 2022

Contact Details

Dr Christopher Poon

:

GO ID:
GO4813
Agency:
Cancer Australia
Close Date & Time:
1-Sep-2021 5:00 pm (ACT Local Time)
Show close time for other time zones
Primary Category:
231004 - Cancer
Publish Date:
6-May-2021
Location:
ACT, NSW, VIC, SA, WA, QLD, NT, TAS
Selection Process:
Targeted or Restricted Competitive


Description:

The Priority-driven Collaborative Cancer Research Scheme is an innovative annual national research project grants funding scheme which brings together government and other funders to collaboratively fund cancer research in Australia.


Eligibility:

PdCCRS applications will only be accepted if an application has been submitted to NHMRC’s Ideas Grants or Clinical Trials and Cohort Studies Grants schemes and a corresponding PdCCRS Questions application form has been submitted to Cancer Australia.

PdCCRS applications will only be accepted from NHMRC-approved Administering Institutions. A list of NHMRC-approved Administering Institutions and NHMRC’s Administering Institution Policy are available on NHMRC’s website.

The PdCCRS adheres to the relevant Ideas Grants guidelines or the Clinical Trials and Cohort Studies Grants guidelines published by NHMRC, unless otherwise stated in this document.

An eligibility ruling may be made by Cancer Australia at any stage following the close of applications, including during the assessment period.

Instructions for Application Submission:

Applicants are required to complete and submit a grant application to the National Health and Medical Research Council (NHMRC) Ideas Grants or Clinical Trials and Cohort Studies Grants schemes via the NHMRC granting system, indicating that the application is to be considered for funding by Cancer Australia. Applicants are also required to complete the relevant PdCCRS Questions application form for submission directly to Cancer Australia.

Addenda Available:

Contact Details

Dr Christopher Poon

: